Condition: Aortic Valve Stenosis · Structural Valve Deterioration · Sponsor: Fundación EPIC
The VIVALL-2 study is a randomized trial to compare the self-expandable supra-annular Allegra and the balloon-expandable intra-annular Edwards transcatheter valve systems in patients with degenerated biological aortic surgical valve.
This description comes directly from the study's public registry record.
RAÚL MORENO GÓMEZ, MD, PhD · 0034917277000 · raulmorenog@hotmail.com
FUNDACION EPIC · 0034987876135 · iepic@fundacionepic.org
Always discuss trial participation with your own doctor first.
| Azienda Ospedaliero- Universitaria di Alessandria | Alessandria, Italy | Recruiting |
| Azienda Ospedaliera di Perugia | Perugia, Italy | Recruiting |
| Hospital Universitari de Bellvitge | L'Hospitalet de Llobregat, Spain | Recruiting |
| Hospital Clinico San Carlos | Madrid, Spain | Recruiting |
| Hospital Universitario de La Paz | Madrid, Spain | Recruiting |
| Hospital Universitario Puerta De Hierro | Majadahonda, Spain | Recruiting |
| Hospital Clínico Universitario de Salamanca | Salamanca, Spain | Recruiting |
| Hospital Universitari I Politècnic de La Fe | Valencia, Spain | Recruiting |
| Manchester University NHS Foundation Trust | Manchester, United Kingdom | Recruiting |
| Freeman Hospital | Newcastle, United Kingdom | Recruiting |
| Morriston Hospital, Swansea | Swansea, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06049654